By Timothy S. Donahue
Top Takeaways:
- National rollout: Altria is expanding on! PLUS nicotine pouches to retailers across the U.S.
- FDA milestone: The product is one of the first to be cleared under the FDA’s nicotine pouch pilot program.
- Portfolio push: The launch enhances Altria’s standing in the rapidly expanding oral nicotine market.
Altria Group is expanding its presence in the nicotine pouch market, announcing the nationwide retail rollout of its on! PLUS product line after initial regional launches and FDA authorization.
The company announced that wholesale shipments started on March 16, with products expected to arrive at participating retailers nationwide beginning March 23, marking an important move in Altria’s effort to expand into smoke-free alternatives.
“The national expansion of on! PLUS is an exciting milestone for Helix and a meaningful step forward in Altria’s Vision of Moving Beyond Smoking,” said Nick MacPhee, managing director of Helix Innovations, Altria’s oral nicotine subsidiary. “As adult consumers continue to seek smoke-free alternatives, on! PLUS reflects our focus on quality, innovation, and responsibly meeting demand within science-based regulatory frameworks.”
On! PLUS were the first nicotine pouch products authorized through the FDA’s pilot program aimed at speeding up premarket tobacco product applications (PMTAs) for the fast-growing category.
The national rollout expands on previous availability through e-commerce and select retail markets in North Carolina, Florida, and Texas. The FDA-authorized lineup includes six SKUs across three flavors—Mint, Tobacco and Wintergreen—each available in 6 mg and 9 mg nicotine strengths.
Altria’s expansion occurs as the U.S. nicotine pouch market continues to grow quickly, driven by consumer demand for smoke-free products and rising competition among major tobacco firms and independent producers.
